查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1787002

个人化医疗市场，规模，占有率，趋势，产业分析报告:各产品，各最终用途，各地区-2025～2034年市场预测

Personalized Medicine Market Size, Share, Trend, Industry Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Others), By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，个人化医疗市场规模预计到 2034 年将达到 1.3 兆美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

个人化医疗市场专注于利用基因、环境和生活方式数据来指导临床决策，并根据每位患者的独特特征制定个人化治疗方案。基因组定序、分子诊断和生物资讯学的快速发展彻底改变了传统医疗保健，使预测、预防和精准干预成为可能。生物标记引导疗法的临床整合正在重塑肿瘤学、神经病学和心臟病学领域的治疗方案。对价值导向医疗的日益重视，加速了对标靶治疗的需求，这些疗法可以最大限度地减少副作用并改善疗效。直接面向消费者的基因检测的兴起和患者意识的不断增强，正在扩大获得客製化健康和预防策略的管道。

製药公司正在投资生物标记发现和伴随诊断，以优化临床检测结果和监管审批效率。市场趋势包括向多组学分析、人工智慧决策工具和个人化数位疗法的转变。将个人化照护模式整合到初级保健框架中，并利用电子健康记录来支持临床基因组数据整合，这些数据都蕴藏着机会。支付方对精准医疗报销的兴趣日益浓厚，这正在创造新的商业途径。

专注于罕见疾病基因组学和分层医疗计划的公私合作伙伴关係正在加强创新管道。诊断、治疗和数据科学的融合正在释放个人化医疗的全部潜力，使其成为现代医疗保健的核心支柱。个人化营养和以微生物学为重点的干预措施日益被接受，也预示着向整体健康管理的更广泛转变。随着利害关係人整合临床效用、技术能力和监管支持，以推动个人化医疗解决方案，个人化医疗市场预计将在未来几年快速发展。

个人化医疗市场报告重点

依产品类型划分，个人化营养与健康领域将在2024年占据约33%的销售额。消费者对预防医学和生活方式相关疾病的认识不断提高，推动了对客製化营养健康解决方案的需求。

依最终用途划分，医院领域将在2024年占据最大占有率。先进的基础设施和广泛的分子检测平台使医院成为实施精准医疗的关键枢纽。

受基因组技术、先进诊断技术和精准医疗在临床环境中广泛应用的推动，北美将在2024年占40%的销售额。

预计亚太地区个人化医疗市场在2025年至2034年间的复合年增长率将达到12.2%。人口密集国家对个人化医疗的需求快速增长、医疗保健支出的增加以及基因组服务管道的不断扩大，正在推动市场扩张。

全球主要公司包括雅培（Abbott）、ASURAGEN, INC.、Biogen、Celera Diagnostics LLC.、Dako A/S、丹纳赫集团（Cepheid, Inc.）、Decode Genetics, Inc.、Exact Sciences Corporation、Exagen Inc.、GE Healthcare、Genelex、Illcode Genetics, Inc.、Exact Sciences Corporation、Exagen Inc。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球个人化医疗市场洞察

  • 市场概述
  • 个人化医疗市场动态
    • 促进因素和机会
      • 慢性病和罕见病患病率不断上升
      • 製药和生技公司加大研发投入
    • 限制与挑战
      • 高昂的开发和诊断成本
  • PESTEL分析
  • 个人化医疗市场用途趋势
  • 价值链分析

第5章 全球个人化医疗市场:各产品

  • 主要调查结果
  • 简介
  • 个人化医疗诊断
  • 个人化医疗治疗
  • 个人化医疗
  • 个体化营养和健康

第6章 全球个人化医疗市场:各最终用途

  • 主要调查结果
  • 简介
  • 医院
  • 诊断中心
  • 研究·学术机构
  • 其他

第7章 全球个人化医疗市场:地区

  • 主要调查结果
  • 简介
    • 个人化医疗市场评估:地区，2020～2034年
  • 北美
    • 北美:各产品，2020～2034年
    • 北美:各最终用途，2020～2034年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲:各产品，2020～2034年
    • 欧洲:各最终用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他的欧洲
  • 亚太地区
    • 亚太地区:各产品，2020～2034年
    • 亚太地区:各最终用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他的亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020～2034年
    • 中东·非洲:各最终用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他的中东·非洲
  • 南美
    • 南美:各产品，2020～2034年
    • 南美:各最终用途，2020～2034年
    • 巴西
    • 阿根廷
    • 其他的南美

第8章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第9章 企业简介

  • Abbott
  • ASURAGEN, INC.
  • Biogen
  • Celera Diagnostics LLC.
  • Dako A/S
  • Danaher Corporation(Cepheid, Inc.)
  • Decode Genetics, Inc.
  • Exact Sciences Corporation
  • Exagen Inc.
  • GE Healthcare
  • Genelex
  • Illumina, Inc.
  • Precision Biologics
  • QIAGEN
Product Code: PM5986

The personalized medicine market size is expected to reach USD 1,300.20 billion by 2034, according to a new study by Polaris Market Research. The report "Personalized Medicine Market Size, Share, Trend, Industry Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Others), By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The personalized medicine market focuses on tailoring medical treatment to the individual characteristics of each patient, using genetic, environmental, and lifestyle data to guide clinical decisions. Rapid advances in genomic sequencing, molecular diagnostics, and bioinformatics have transformed traditional healthcare by enabling predictive, preventive, and precisely targeted interventions. The integration of biomarker-based therapies into clinical practice is reshaping treatment protocols across oncology, neurology, and cardiology. Increasing emphasis on value-based care is accelerating demand for targeted drugs that minimize adverse effects and improve therapeutic outcomes. The growth in direct-to-consumer genetic testing and increasing patient awareness is expanding access to customized wellness and preventive strategies.

Pharmaceutical companies are investing in biomarker discovery and companion diagnostics to optimize clinical trial outcomes and regulatory approval efficiency. Market trends include a shift toward multi-omics profiling, AI-powered decision-making tools, and personalized digital therapeutics. Opportunities lie in integrating personalized care models into primary care frameworks and leveraging electronic health records to support clinical-genomic data convergence. Increasing interest from payers in covering precision medicine therapies is creating new commercial pathways.

Public-private partnerships focused on rare disease genomics and stratified medicine initiatives are enhancing innovation pipelines. The convergence of diagnostics, therapeutics, and data science is unlocking the full potential of personalized care, making it a central pillar of modern medicine. Growing acceptance of personalized nutrition and microbiome-focused interventions also signals a broader shift toward holistic health management. The personalized medicine market is expected to evolve rapidly in the coming years as stakeholders align clinical utility, technological capabilities, and regulatory support to advance individualized healthcare solutions.

Personalized Medicine Market Report Highlights

By product, the personalized nutrition & wellness segment accounted for ~33% of the revenue share in 2024. Growing consumer awareness about preventive healthcare and lifestyle-related diseases has increased the demand for tailored nutrition and wellness solutions.

Based on end use, the hospitals segment accounted for the largest share in 2024. Advanced infrastructure and broader access to molecular testing platforms make hospitals key centers for implementing precision medicine.

North America accounted for ~40% of the revenue share in 2024 due to high adoption of genomic technologies, advanced diagnostics, and precision therapeutics across clinical settings.

The personalized medicine market in Asia Pacific is expected to register a CAGR of 12.2% from 2025 to 2034, as surging demand for tailored healthcare in densely populated countries, rising healthcare spending, and growing access to genomic services are driving expansion.

A few global key players include Abbott; ASURAGEN, INC.; Biogen; Celera Diagnostics LLC.; Dako A/S; Danaher Corporation (Cepheid, Inc.); Decode Genetics, Inc.; Exact Sciences Corporation; Exagen Inc.; GE Healthcare; Genelex; Illumina, Inc.; Precision Biologics; and QIAGEN.

Polaris Market Research has segmented the personalized medicine market report on the basis of product, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Personalized Medicine Diagnostics

Genetic Testing

Direct-To-Consumer (DTC) Diagnostics

Others

Personalized Medicine Therapeutics

Pharmaceutical

Genomic Medicine

Medical Devices

Personalized Medical Care

Personalized Nutrition & Wellness

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Diagnostic Centers

Research & Academic Institutes

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Personalized Medicine Market Insights

  • 4.1. Personalized Medicine Market - Market Snapshot
  • 4.2. Personalized Medicine Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Chronic and Rare Diseases
      • 4.2.1.2. Increased Investment in R&D by Pharma and Biotech Firms
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High development and diagnostic costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Personalized Medicine Market Application Trends
  • 4.6. Value Chain Analysis

5. Global Personalized Medicine Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Personalized Medicine Diagnostics
    • 5.3.1. Global Personalized Medicine Market, by Personalized Medicine Diagnostics, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Genetic Testing
      • 5.3.2.1. Global Personalized Medicine Market, by Genetic Testing, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Direct-To-Consumer (DTC) Diagnostics
      • 5.3.3.1. Global Personalized Medicine Market, by Direct-To-Consumer (DTC) Diagnostics, by Region, 2020-2034 (USD Billion)
    • 5.3.4. Others
      • 5.3.4.1. Global Personalized Medicine Market, by Others, by Region, 2020-2034 (USD Billion)
  • 5.4. Personalized Medicine Therapeutics
    • 5.4.1. Global Personalized Medicine Market, by Personalized Medicine Therapeutics, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Pharmaceutical
      • 5.4.2.1. Global Personalized Medicine Market, by Pharmaceutical, by Region, 2020-2034 (USD Billion)
    • 5.4.3. Genomic Medicine
      • 5.4.3.1. Global Personalized Medicine Market, by Genomic Medicine, by Region, 2020-2034 (USD Billion)
    • 5.4.4. Medical Devices
      • 5.4.4.1. Global Personalized Medicine Market, by Medical Devices, by Region, 2020-2034 (USD Billion)
  • 5.5. Personalized Medical Care
    • 5.5.1. Global Personalized Medicine Market, by Personalized Medical Care, by Region, 2020-2034 (USD Billion)
  • 5.6. Personalized Nutrition & Wellness
    • 5.6.1. Global Personalized Medicine Market, by Others, by Personalized Nutrition & Wellness, 2020-2034 (USD Billion)

6. Global Personalized Medicine Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Personalized Medicine Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 6.4. Diagnostic Centers
    • 6.4.1. Global Personalized Medicine Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
  • 6.5. Research & Academic Institutes
    • 6.5.1. Global Personalized Medicine Market, by Research & Academic Institutes, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Personalized Medicine Market, by Othersr, by Region, 2020-2034 (USD Billion)

7. Global Personalized Medicine Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Personalized Medicine Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Personalized Medicine Market - North America
    • 7.3.1. North America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.3.2. North America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.3. Personalized Medicine Market - U.S.
      • 7.3.3.1. U.S.: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.4. Personalized Medicine Market - Canada
      • 7.3.4.1. Canada: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.5. Personalized Medicine Market - Mexico
      • 7.3.5.1. Mexico: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.3.5.2. Mexico: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 7.4. Personalized Medicine Market - Europe
    • 7.4.1. Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.3. Personalized Medicine Market - UK
      • 7.4.3.1. UK: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.4. Personalized Medicine Market - France
      • 7.4.4.1. France: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.5. Personalized Medicine Market - Germany
      • 7.4.5.1. Germany: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.6. Personalized Medicine Market - Italy
      • 7.4.6.1. Italy: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.7. Personalized Medicine Market - Spain
      • 7.4.7.1. Spain: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.8. Personalized Medicine Market - Netherlands
      • 7.4.8.1. Netherlands: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.9. Personalized Medicine Market - Russia
      • 7.4.9.1. Russia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.10. Personalized Medicine Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 7.5. Personalized Medicine Market - Asia Pacific
    • 7.5.1. Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.3. Personalized Medicine Market - China
      • 7.5.3.1. China: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.4. Personalized Medicine Market - India
      • 7.5.4.1. India: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.5. Personalized Medicine Market - Malaysia
      • 7.5.5.1. Malaysia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.6. Personalized Medicine Market - Japan
      • 7.5.6.1. Japan: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.7. Personalized Medicine Market - Indonesia
      • 7.5.7.1. Indonesia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.8. Personalized Medicine Market - South Korea
      • 7.5.8.1. South Korea: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.9. Personalized Medicine Market - Australia
      • 7.5.9.1. Australia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.10. Personalized Medicine Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 7.6. Personalized Medicine Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.3. Personalized Medicine Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.4. Personalized Medicine Market - UAE
      • 7.6.4.1. UAE: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.5. Personalized Medicine Market - Israel
      • 7.6.5.1. Israel: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.6. Personalized Medicine Market - South Africa
      • 7.6.6.1. South Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.7. Personalized Medicine Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 7.7. Personalized Medicine Market - Latin America
    • 7.7.1. Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.3. Personalized Medicine Market - Brazil
      • 7.7.3.1. Brazil: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.7.3.2. Brazil: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.4. Personalized Medicine Market - Argentina
      • 7.7.4.1. Argentina: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.7.4.2. Argentina: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.5. Personalized Medicine Market - Rest of Latin America
      • 7.7.5.1. Rest of Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.7.5.2. Rest of Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. ASURAGEN, INC.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Biogen
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Celera Diagnostics LLC.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Dako A/S
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Danaher Corporation (Cepheid, Inc.)
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Decode Genetics, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Exact Sciences Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Exagen Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. GE Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Genelex
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Illumina, Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Precision Biologics
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. QIAGEN
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development

List of Tables:

  • Table 1 Global Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 3 North America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 4 North America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 U.S.: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 6 U.S.: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 Canada: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 8 Canada: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 Mexico: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 10 Mexico: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 11 Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 12 Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 UK: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 14 UK: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 15 France: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 16 France: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Germany: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Germany: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 Italy: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 20 Italy: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 Spain: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 22 Spain: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 23 Netherlands: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 24 Netherlands: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Russia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Russia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 27 Rest of Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 28 Rest of Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 30 Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 China: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 32 China: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 India: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 34 India: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 35 Malaysia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 36 Malaysia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Japan: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Japan: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 39 Indonesia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 40 Indonesia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 South Korea: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 42 South Korea: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 Australia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 44 Australia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Rest of Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Rest of Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 47 Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 48 Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Saudi Arabia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Saudi Arabia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 51 UAE: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 52 UAE: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 Israel: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 54 Israel: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 South Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 56 South Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 Rest of Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 58 Rest of Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 59 Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 60 Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Brazil: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Brazil: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 63 Argentina: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 64 Argentina: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Personalized Medicine Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Personalized Medicine Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Personalized Medicine Market, by End Use, 2024 & 2034 (USD Billion)